Intent to Sole Source Notice-5 Year IDIQ for Chemistry, Immunochemistry, and Hematology Testing with Remisol Advanced Software Auto Verification Wilkes-Barre VA Medical Center

The contract seeks to secure instrumentation, reagents, and associated services for Clinical Laboratory Chemistry, Immunochemistry, Chemiluminescent, and Hematology Testing on an automated line with auto-verification capabilities at the Wilkes-Barre VA Medical Center. A critical requirement is the continued support and maintenance of the existing Remisol Advance software and the Data Innovations Instrument Manager wrapper rules, which govern the auto-verification process for test results. The vendor must ensure seamless integration of new rules and updates to maintain the integrity and efficiency of the current diagnostic workflow without disrupting laboratory operations. This includes ongoing technical support, software compatibility, and system enhancements aligned with the center's automated verification infrastructure. This is a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract issued under solicitation number 36C24426Q0756 by the Department of Veterans Affairs through the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania. The notice was posted on July 2, 2026, with proposals due by July 8, 2026. No small business set-aside is applicable, and the North American Industry Classification System code is 334516, indicating medical and dental equipment manufacturing. The place of performance is specifically designated as Wilkes-Barre, Pennsylvania, and all technical and operational support must be delivered to meet the center’s specific system requirements. Point of contact for inquiries is Christa Stine, reachable by phone or email.